Clinical TrialsSearch results
Number of results: 193
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)
- Impaired glucose tolerance (IGT)
- Takeda Pharmaceutical Company Limited
- 2008-04-07
Other
- A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants with Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy
- hidradenitis suppurativa
- Otani Tetsuya
- 2022-05-28
Recruiting
- A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
- Generalized Myasthenia Gravis
- Pavani Rodrigo
- 2022-10-18
Other
- A Switch Therapy for Community-acquired Pneumonia: A Randomized Controlled Trial
- Community-acquired pneumonia in adults
- Nagasaki evaluation organization for clinical interventions
- 2009-07-01
Other
- Additional JET Study for Patients during Maintenance Phase(Co-JET Study)
- maintenance-phase renal failure (predialysis renal failure)
- Scientific Advisory Committee (SAC)
- 2005-10-01
Recruiting
- ADR-04
- Highly chronic lower extremity deficiency blood included
- furukawa kojiro
- 2022-04-23
Other
- Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT)
- Diabetic peripheral neuropathy
- The Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT) Study Group
- 2007-02-20
Other
- An exploratory research for a case with peripheral artery disease as a complication of lumbar spinal canal stenosis.
- lumbar spinal canal stenosis
- Fukushima medical university school of medicine
- 2008-12-05
Not yet recruiting
- An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB
- Mucopolysaccharidosis IIIB
- Wakita Ryo
- 2024-07-30
Other
- An Open-Label Randomized Phase III Study of Capecitabine(6 months) versus Capecitabine(12 months) as Adjuvant Chemotherapy for Stage III(Dukes'C) Colon Cancer Patients.
- Colon cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2008-09-10